Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey
暂无分享,去创建一个
[1] P. Gisondi,et al. Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies , 2020, Vaccines.
[2] K. Reich,et al. The value of subcutaneous vs. oral methotrexate: real‐world data from the German psoriasis registry PsoBest , 2020, The British journal of dermatology.
[3] C. Poreaux,et al. Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19 , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] B. Strober,et al. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies , 2020 .
[5] M. Tauber,et al. French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] J. Perrot,et al. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France. , 2019, Annales de dermatologie et de venereologie.
[7] C. Bodemer,et al. Sex‐ and age‐adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.
[8] S. Marciano,et al. Real world prescription trends of methotrexate for psoriasis in Argentina: results of a national survey , 2017, The Journal of dermatological treatment.
[9] R. Warren,et al. British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016 , 2016, The British journal of dermatology.
[10] L. Hooft,et al. Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation. , 2016, Acta dermato-venereologica.
[11] L. Naldi,et al. Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[12] A. Dhillon,et al. Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies , 2014, The British journal of dermatology.
[13] L. Misery,et al. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.
[14] C. Griffiths,et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus , 2010, Archives of Dermatological Research.